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ABSTRACT 
Background/Aims: To clarify parameters associated with postoperative surgical site infection 
(SSI) after pancreatectomy, we examined clinicopathological and surgical records in 186 
patients who underwent pancreatectomy at a single academic institute.  
Methodology: Patient demographics, liver functional parameters, histological findings, 
surgical records and post-hepatectomy outcomes during hospitalization were compared 
between the non-SSI and SSI group, in which SSIs included superficial and deep SSIs. 
Results:  The prevalence of SSI (29-35%) has not changed over an 18-year period. With 
respect to patient demographics and laboratory data, no parameters were associated with 
postoperative SSI. In surgical records, the operating time in the SSI group tended to be longer 
in comparison with that in the non-SSI group (618 vs. 553 minutes, respectively) but not 
significantly different (p=0.070). With respect to postoperative outcomes, time to oral intake in 
the SSI group was significantly longer than that in the non-SSI group (21.2 vs. 13.7 days, 
respectively) (p<0.01). Incidences of pancreatic fistula, postoperative bleeding, long-term 
ascites and re-operation were significantly more frequent in the SSI group in comparison with 
the non-SSI group (p<0.05). Decrease of body weight after surgery in the SSI group was 
significantly greater than that in the non-SSI group (-4.1 vs. -2.7kg, respectively) (p<0.05). 
Period of hospital stay in the SSI group was significantly longer than that in the non-SSI group 
(37 vs. 25 days) (p<0.05). Multivariate analysis showed that only postoperative pancreatic 
fistula was significantly associated with SSI (p<0.01). 
Conclusions: SSI is an important risk factor of longer hospital stay after pancreatectomy and 
prevention of pancreatic fistula through the future improvement of surgical procedures is 
necessary to decrease SSI rates.  
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INTRODUCTION 
Pancreatic resection is an invasive surgery leading to substantial blood loss, requiring red 
cell transfusion rate, physiological stress, and postoperative complications (e.g., pancreatic 
fistula and its related abscess formation or pseudoaneurysm). [1] Recently, perioperative 
management has been dramatically improved and surgical techniques using hemostatic devices 
or laparoscopic techniques have also been improved [1]. However, even with the improvement 
of pancreatic surgery, pancreatectomy-related surgical site infections (SSIs) are still a concern 
[2]. Organ SSIs in deep lesions are likely due to 1) fluid collection of pancreas juice or clots 2) 
medical instruments such as drainage tubes and staples, or 3) organ injury areas. Incisional 
SSIs in superficial lesions of the abdominal wall may be due to 1) exposure of digestive tract 
fluid or blood during operation or 2) bacteria flora usually located in the patient’s skin. It is 
important to clarify the pancreatectomy-related parameters associated with SSIs within deep 
and superficial lesions, and it is necessary to take measures to avoid these SSI-associated 
factors. Several investigators have reported factors associated with SSI in patients who 
underwent pancreatectomy. [2-4]. In the present study, we aimed to further clarify these results 
by examining various clinicopathological and surgical parameters and determine changes over 
different time periods at a Japanese single cancer institute. Based on the present results, we 
propose measures to reduce the prevalence of SSIs. 
     In the present study, we examined perioperative clinicopathological parameters, 
experiences of surgeons, surgical records and postoperative morbidity and mortality in 186 
patients with various pancreatic diseases who underwent pancreatectomy between 1994 and 
2012. In 2004, the chief operator was changed although the first author continued to work as 
part of the same group for the entire period. We began to apply hemostatic vessel sealing 
devices in 2008. Therefore, the time periods were divided into three groups as group 1 
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(1994-2003), group 2 (2004-2007) and group 3 (2008-2012). Based on the results, we aimed to 
consider future strategies for SSI prevention during pancreatic surgery at our cancer institute.  
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METHODOLOGY 
Patients 
A total of 186 consecutive patients (124 men, 62 women) undergoing hepatic resection in the 
Division of Surgical Oncology and Department of Surgery at Nagasaki University Graduate 
School of Biomedical Sciences (NUGSBS) between 1994 and 2012 were analyzed. Mean and 
median age for patients at the time of surgery was 64.8 ± 12.3 and 66 years (range, 18-87 years). 
Subjects were divided by time periods: Term 1 had hepatectomy between 1994 and 2003 and 
included 54 patients (29%), term 2 was between 2000 and 2007 and included 99 patients (53%), 
and term 3 was between 2008 and 2012 and included 33 patients (18%). Background pancreas 
was normal in 115 patients (62%), and subacute pancreatitis was observed in 53 patients (29%), 
chronic pancreatitis in 9 (5%) and fatty pancreas in 7 (4%). Pancreas diseases were ampulla 
carcinoma in 21 patients (11%), bile duct carcinoma in 39 patients (21%), gallbladder 
carcinoma in five (3%), pancreatic ductal carcinoma in 60 (32%), duodenal tumors in four 
(2%), intraductal papillary mucin-producing neoplasm in 26 (14%), pancreatic neuroendocrine 
tumor in six (3%), chronic pancreatitis in nine (5%), and other benign liver diseases in 16 (9%). 
Diabetes mellitus was observed in 67 patients (36%), habit of smoking in 71 patients (38%), 
habit of alcohol every day in 82 (44%), co-existing pancreatitis in 51 (27%), and obesity (body 
mass index>25) in 36 (19%), respectively. The pancreatic functioning diagnostant (PFD) 
testing using N-benzoyl-l-tyrosyl-p-aminobenzoic acid was examined in 90 patients (48%). All 
study protocols were approved by the Human Ethics Review Board of our institution. Informed 
consent for data collection was obtained from each patient during this period. Anesthetic and 
patient data were retrieved from the NUGSBS database. 
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Comparison of clinicopathological features, surgical records and postoperative 
outcomes. 
Clinical data, co-morbidities, general status, conventional laboratory data, surgical data and 
pancreatectomy-related complications were analyzed. Evaluation of background pancreas and 
the main diseases were confirmed by histopathological examination of the resected specimen 
in all patients. We referred to the findings of the Classification of Pancreatic Carcinoma and 
Classification of Biliary Tract Carcinoma in biliary and pancreatic malignancies [5, 6]. The 
main operator was the teaching staff in 129 (69%) and fellowship or resident surgeon in 57 
(31%). Operative procedures included pancreaticoduodenectomy (n=140; 75%), distal 
pancreatectomy (n=39; 21%) and central pancreatectomy (n=6; 3%) and Frey’s 
pancreaticojejunostomy (n=1; 1%). All hepatic tumors were completely resected without 
macroscopic exposure of the amputated section to the remaining liver.  
 
Statistical analysis 
All continuous data are expressed as mean ±SD and median value. Differences were examined 
using one-way analysis of variance (ANOVA) and Student’s t-test. Correlations between the 
two parameters were examined by calculating the Pearson’s correlation coefficient. 
Categorical data were analyzed using Fisher’s exact test. Potentially predictive variables were 
identified using a significance level of p<0.05 by univariate analysis and the identified factors 
were then entered into the multiple logistic regression analysis. A two-tailed value of P<0.05 
was considered statistically significant. SPSS for Windows version 18.0 (SPSS, an IBM 
Company, Chicago, IL) was used for all statistical analyses. 
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RESULTS 
   Table 1 shows the prevalence of SSIs in the different periods. The prevalence of SSIs did not 
change significantly over the different periods examined from the past 18 years. 
   Table 2 shows the relationship between SSIs and demographics of patients who underwent 
pancreatectomy. Age, gender, background or main diseases of peripancreas lesions, habit, 
co-morbidity, general status and preoperative laboratory data were not significantly associated 
with occurrence of SSI.  
  Table 3 shows the surgical records. Operating time in the SSI group tended to be longer than 
that in the non-SSI group but this difference was not significant (p=0.070). Operators, incision, 
operating procedures, use of fibrin glue, blood loss, transfusion and architecture of pancreas 
were not significantly associated with occurrence of SSI.  
Table 4 shows the patient outcomes. Time to oral intake after pancreatectomy in the SSI 
group was significantly longer than that in the non-SSI group (p<0.01). Incidences of 
pancreatic fistula, postoperative bleeding, long-term ascites, and reoperation in the SSI group 
were significantly more frequent in comparison with those in the non-SSI group (p<0.05). 
Decrease of body weight after pancreatectomy in the SSI group was significantly greater than 
that in the non-SSI group (p<0.05). Period of hospital stay in the SSI group was significantly 
longer than that in the non-SSI group (p<0.05). 
Table 5 shows the risk ratio of parameters associated with SSI by multivariate analysis 
using the parameters. Only each grade of pancreatic fistula by the ISGPF classification was 
significantly associated with the occurrence of SSI (p<0.01).  
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DISCUSSION 
 Surgical site infection (SSI) is a major postoperative complication in pancreatic surgery 
and this complication may cause prolonged hospital stay. [2-4, 7-9]. Although SSI has been 
improved by the development of perioperative management, problematic issues remain. SSI is 
defined as infection in the superficial (incisional) and deep (organ space) sites [10]. In the 
present study, however, distinction of both SSI types was difficult using only patient charts and 
therefore we examined all cases of SSI together. As postoperative complications may improve 
over time [11], we firstly examined the changes of prevalence of SSI. However, the incidence 
of SSI was around 30% for all periods during the 18 years examined, with no improvement 
observed at our institute, even though we used absorbable materials and the latest vessel 
sealing devices. Previous reports showed the rate of SSI after pancreatectomy was higher than 
that in other gastrointestinal surgeries, which ranged between 20-40% [2, 3] The rate of SSI in 
the present study was within in a similar range. With respect to the prevention of postoperative 
infection, prophylactic antibiotics, such as the third-generation cephem antibiotics, 
administered by drip infusion were used for 7 days after pancreatectomy in the 1990s in our 
series. However, these prophylaxes might not be necessary because reliable evidence regarding 
effectiveness has not been fully elucidated. At the present stage, we have stopped such 
prophylactic treatment and the prevalence of SSI was not different. Shaving of pubic hair was 
previously performed to prevent incisional SSI at our institute; however, this procedure was 
also ceased in 2002 because no reliable evidence of its efficacy had been reported. Since 2004, 
silk sutures have been exchanged for absorbable materials to prevent SSI at our institute. When 
the abdominal wound is closed, we fully wash the intra-abdominal space using a large amount 
of saline to decrease the amount of remnant microorganisms. When the abdominal wall is 
closed, the incised wounds are again washed with a jet stream of saline.  
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 The relationship between clinical and surgical features with SSI was examined. Although 
older age, diabetes, and co-morbidities present before surgery were previously reported to be 
associated with SSI [1-4, 7-9], in our study, no preoperative factors were significantly 
associated with SSI. Regarding diabetes, glycemic control was effective to prevent SSIs in 
patients undergoing pancreatectomy [12]. During the period of our study, strict management to 
control blood sugar after surgery was performed. Performance status might be associated with 
SSI in abdominal surgery. Patients with these parameters might have lower immunity 
according to worsening of systemic physiological functions. However, such a general status 
was not associated with SSI after pancreatectomy in the present study.  
With respect to surgical records, in previous reports, patients who underwent laparoscopic 
operations showed low rates of SSI, likely because these operations are less invasive than 
laparotomy [1]. Gram-positive bacteria, such as a methicillin-resistance Staphylococcus 
aureus, were often detected on the surface wound [13]. However, the rate of SSI was not 
significantly decreased in patients undergoing laparoscopic pancreatectomy in comparison 
with conventional pancreatectomy in our study. Combined resections of surrounding vessels or 
intestinal anastomosis have also been proposed as risk factors of SSI; however, no significant 
relationship between SSI and these procedures was observed. Operating time tended to be 
significantly associated with SSI [14]. Longer exposure to air may increase the risk of 
attachment of microorganisms in the surgical field. Other surgical parameters, including blood 
loss, which was thought to be a risk factor [15], were not associated with the rate of SSI in the 
present study. 
      With respect to patient outcomes, SSIs frequently occurred when any postoperative 
complications were observed. Events of pancreatectomy-related complications might cause 
intra-abdominal infection due to deterioration of immunological defense mechanism as 
bacterial translocation or sepsis. Time to oral intake and body weight loss were also associated 
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with SSI in the present study. Such conditions might deteriorate nutritional status and 
immunological response, leading to SSI. On the other hand, this phenomenon might be a result 
of the occurrence of SSI or associated conditions [16]. Pancreatic fistula inducing enzyme 
activity of pancreas juice often causes intra-abdominal infection in the surgical space [17]. By 
multivariate analysis, the presence of pancreatic fistula was the most significant risk factor for 
SSI in the present study. Prevention of pancreatic fistula is necessary to reduce occurrence of 
SSI or hospital stay. However, the incidence of pancreatic fistula has not improved, even in the 
modern era, as previously reported [18]. More advanced surgical techniques to reduce 
pancreatic fistula in pancreatectomy are necessary in the future. Hospital-stay length was 
significantly affected by the high prevalence of post-pancreatectomy complications and deep 
SSI. SSI was thought to be an important factor affecting patient survival prognosis because this 
causes systemic sepsis and additional multi-organ dysfunction.  Thus, occurrence of SSI is a 
risk factor for patient outcomes and prolonged hospital stay.  
   In conclusion, we have demonstrated the prevalence of SSI and we analyzed the 
relationship among SSI, surgical records and patient outcomes in patients with various diseases 
who underwent pancreatic resections. Prevalence of SSI did not change in the different time 
periods studied. Longer operating time, time to postoperative oral intake, postoperative 
complications and greater body weight loss were associated with SSI by univariate analysis 
and SSI was associated with longer hospital stay. Multivariate analysis showed that the 
presence of pancreas fistula and the degree of severity of pancreas fistula were independently 
associated with SSI. Preventing pancreatic fistula through advances in surgical procedures is 
important to reduce the prevalence of SSI and related patient outcomes. 
  
  
Nanashima et al., Page 12 
REFERENCES 
1. Briggs CD, Mann CD, Irving GR, Neal CP, Peterson M, Cameron IC, Berry DP: 
Systematic review of minimally invasive pancreatic resection. J Gastrointest Surg. 
2009 ;13:1129-37.  
2. Nakahira S, Shimizu J, Miyamoto A, Kobayashi S, Umeshita K, Ito T, Monden M, 
Doki Y, Mori M: Proposal for a sub-classification of hepato-biliary-pancreatic operations for 
surgical site infection surveillance following assessment of results of prospective multicenter 
data. J Hepatobiliary Pancreat Sci. 2013 (E-Pub). 
3. Okabayashi T, Nishimori I, Yamashita K, Sugimoto T, Yatabe T, Maeda H, 
Kobayashi M, Hanazaki K: Risk factors and predictors for surgical site infection after hepatic 
resection. J Hosp Infect. 2009;73:47-53. 
4. Halloran CM, Ghaneh P, Bosonnet L, Hartley MN, Sutton R, Neoptolemos JP: 
Complications of pancreatic cancer resection. Dig Surg. 2002;19:138-46. 
5. Japan Pancreas Society. In: Kawarada Y ed. Classification of Pancreatic Carcinoma. 
2nd Englsih ed., Tokyo: Kanehara & Co., Ltd., 2003, p.4-33 
6. Japanese Society of Biliary Surgery (JSBS). In: Nagakawa T ed. Classification of 
Biliary Tract Carcinoma. Tokyo: Kanehara & Co., Ltd., 2004, p.11-50. 
7. Kimura F, Shimizu H, Yoshidome H, Ohtsuka M, Kato A, Yoshitomi H, Nozawa S, 
Furukawa K, Mitsuhashi N, Sawada S, Takeuchi D, Ambiru S, Miyazaki M: Increased 
plasma levels of IL-6 and IL-8 are associated with surgical site infection after 
pancreaticoduodenectomy. Pancreas 2006;32:178-85. 
8. Grant FM, Protic M, Gonen M, Allen P, Brennan MF: Intraoperative fluid 
management and complications following pancreatectomy. J Surg Oncol. 2013;107:529-35. 
9. Kent TS, Sachs TE, Callery MP, Vollmer CM Jr.: The burden of infection for elective 
pancreatic resections. Surgery. 2013;153:86-94. 
Nanashima et al., Page 13 
10. Sadamori H, Yagi T, Shinoura S, Umeda Y, Yoshida R, Satoh D, Nobuoka D, 
Utsumi M, Yoshida K, Fujiwara T: Risk factors for organ/space surgical site infection after 
hepatectomy for hepatocellular carcinoma in 359 recent cases. J Hepatobiliary Pancreat Sci. 
2013;20:186-96. 
11. Donahue TR, Reber HA: Pancreatic surgery. Curr Opin Gastroenterol. 
2010;26:499-505. 
12. Hanazaki K: Tight glycemic control using an artificial endocrine pancreas may play an 
important role in preventing infection after pancreatic resection. World J Gastroenterol. 2012 
7;18:3787-9 
13. Kusachi S, Sumiyama Y, Nagao J, Arima Y, Yoshida Y, Tanaka H, Nakamura Y, 
Saida Y, Watanabe M, Watanabe R, Sato J: Prophylactic antibiotics given within 24 hours 
of surgery, compared with antibiotics given for 72 hours perioperatively, increased the rate of 
methicillin-resistant Staphylococcus aureus isolated from surgical site infections. J Infect 
Chemother. 2008;14:44-50 
14. Sadamori H, Yagi T, Shinoura S, Umeda Y, Yoshida R, Satoh D, Nobuoka D, 
Utsumi M, Fujiwara T: Risk factors for major morbidity after liver resection for 
hepatocellular carcinoma. Br J Surg. 2013;100:122-9. 
15. Coakley BA, Divino CM: Identifying factors predictive of surgical-site infections after 
colectomy for fulminant ulcerative colitis. Am Surg. 2012;78:481-4. 
16. Shinkawa H, Takemura S, Uenishi T, Sakae M, Ohata K, Urata Y, Kaneda K, 
Nozawa A, Kubo S: Nutritional risk index as an independent predictive factor for the 
development of surgical site infection after pancreaticoduodenectomy. Surg Today. 
2013;43:276-83. 
Nanashima et al., Page 14 
17. Nagakawa Y, Matsudo T, Hijikata Y, Kikuchi S, Bunso K, Suzuki Y, Kasuya K, 
Tsuchida A: Bacterial contamination in ascitic fluid is associated with the development of 
clinically relevant pancreatic fistula after pancreatoduodenectomy. Pancreas. 2013;42:701-6. 
18. Sukharamwala P, Thoens J, Szuchmacher M, Smith J, DeVito P: Advanced age is a 
risk factor for post-operative complications and mortality after a pancreaticoduodenectomy: a 
meta-analysis and systematic review. HPB. 2012;14:649-57 
Nanashima et al., Page 1 
Table 1. Changes of prevalence of SSIs in different periods 








Superficial SSI (n=32) 17(31%) 27(35%) 15(29%) 0.669 
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Table 2. Patient demographics, co-morbidities, general status and liver functional parameters 










Background chronic pancreatitis 
    Normal/associated pancreatitis/ 
chronic pancreatitis/ fatty pancreas 
Pancreas diseases 
   Pancreatic cancer/ biliary cancer/ 
ampullar cancer/ NET/IPMN/others 
Smoking 
    No/ yes 
Alcohol (drinking every day) 
    No/ yes 
Obesity (BMI>25) 
    No/ yes 
Diabetes 
    No/ yes 
Cardiovascular diseases 
    No/ yes 
Liver disease 
    No/ yes 
Renal diseases 
    No/ yes 
Performance status 
    0/ 1 
ASA physiological status$ 
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    Hemoglobin (g/dl) 
Creatinine (mg/dl) 
Total protein (g/dl) 
Albumin (g/dl) 
Total bilirubin (mg/dl) 
Amylase (U/l) 
Total cholesterol (mg/dl) 
Cholinesterase (mg/dl) 




























NET, neuroendocrine tumor; IPMN, intraductal papillary mucin producing neoplasm; BMI, 
body mass index; $American Society of Anesthesiologists 
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   Teaching staff/fellow/resident 
Incision    
Laparoscopic/abdominal 
Pancreatectomy 
   PD/DP/Others 
Combined resection of liver 
   No/ yes 
Pancreatojejunostomy 
   No/ yes 
Hardness of pancreas 
   Soft/ hard 
Node dissections 
   None/D1/ D2 and 3 
Tube drainage of the main pancreatic duct 
   No/ lost tube/ external drainage 
Use of fibrin glue 
    No/ yes 
Use of vessel sealer 
    No/Yes  
Operating time (minutes) 
Blood loss (ml) 
Red cell transfusion 
    No/ yes 
Use of fresh frozen plasma or albumin 
    No/ yes 
Advanced carcinoma (Stage III and IV) 














































































    0.402 
 
    1.0 
 
    0.932 
 
    0.704 
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Dilatation of main pancreatic duct 






    0.660 
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Time to oral intake (days) 
Complications 
  Pancreatic fistula 
       No/grade A/ grade B and C* 
Postoperative bleeding 
       No/yes 
Long-term ascites 
No/yes 
  Re-operation 
No/yes  
Decrease of body weight (kg) 





































*: Postoperative pancreatic fistula: an international study group (ISGPF) definition 
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Table 5. Relationship between associated parameters and superficial and deep SSI by 
multivariate logistic regression analysis 
 SSI 
 OR (95% CI) P value 
Operating time  
   ≥510minutes vs. <510minutes 
Time to oral intake 
   ≥13days vs. <12days 
Decrease of body weight 
   ≥-3kg vs. <3kg 
Pancreatic fistula* 
   Grade A vs. no 
   Grade BC vs. no 
Postoperative bleeding 
   Yes vs. no 
Long-term ascites 



























Cut-off value was set at the median value of each continuous parameter 
*: Postoperative pancreatic fistula: an international study group (ISGPF) definition 
